Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3DOR

Crystal Structure of mature CPAF

3DOR の概要
エントリーDOI10.2210/pdb3dor/pdb
関連するPDBエントリー3DJA
分子名称Protein CT_858, SULFATE ION (3 entities in total)
機能のキーワードmature cpaf, dimer, transferase
由来する生物種Chlamydia trachomatis
タンパク質・核酸の鎖数2
化学式量合計132230.61
構造登録者
Chai, J.,Huang, Z. (登録日: 2008-07-06, 公開日: 2009-01-13, 最終更新日: 2023-11-01)
主引用文献Huang, Z.,Feng, Y.,Chen, D.,Wu, X.,Huang, S.,Wang, X.,Xiao, X.,Li, W.,Huang, N.,Gu, L.,Zhong, G.,Chai, J.
Structural basis for activation and inhibition of the secreted chlamydia protease CPAF
Cell Host Microbe, 4:529-542, 2008
Cited by
PubMed Abstract: The obligate intracellular pathogen Chlamydia trachomatis is the most common cause of sexually transmitted bacterial disease. It secretes a protease known as chlamydial protease/proteasome-like activity factor (CPAF) that degrades many host molecules and plays a major role in Chlamydia pathogenesis. Here, we show that mature CPAF is a homodimer of the catalytic domains, each of which comprises two distinct subunits. Dormancy of the CPAF zymogen is maintained by an internal inhibitory segment that binds the CPAF active site and blocks its homodimerization. CPAF activation is initiated by trans-autocatalytic cleavage, which induces homodimerization and conformational changes that assemble the catalytic triad. This assembly leads to two autocatalytic cleavages and removal of the inhibitory segment, enabling full CPAF activity. CPAF is covalently bound and inhibited by the proteasome inhibitor lactacystin. These results reveal the activation mechanism of the CPAF serine protease and suggest new opportunities for anti-Chlamydia drug development.
PubMed: 19064254
DOI: 10.1016/j.chom.2008.10.005
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.2 Å)
構造検証レポート
Validation report summary of 3dor
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon